ArticleAnnals of hematology2024

Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers.

Alessandro Laganà et al.PubMed ↗Publisher ↗

No numbers read from the abstract.